| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 04/29/2004 | US20040082796 Reacting a substituted benzonitrile with a cysteine compound |
| 04/29/2004 | US20040082786 Piperazine based inhibitors of factor xa |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082651 Epothilone synthesis building blocks III and IV: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones B, D and epothilone derivatives |
| 04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 04/29/2004 | US20040082638 Compounds, compositions and methods |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082617 Sulphones which modulate the action of gamma secretase |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082571 Substituted piperazines |
| 04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
| 04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1414088A1 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 04/28/2004 | EP1413577A1 Process for production of additives for lubricating oils |
| 04/28/2004 | EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1313724B1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents |
| 04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0881267B1 Azo compounds and process for preparing the same |
| 04/28/2004 | CN1492887A (Cyclo) condensation of isocyanate compounds |
| 04/28/2004 | CN1147469C Novel urea derivatives bearing nitrogenous aromatic heterocycles |
| 04/27/2004 | US6727366 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors |
| 04/27/2004 | US6727282 Human immunodeficiency virus (hiv) or aids treatment |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727238 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 04/22/2004 | WO2004033632A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 04/22/2004 | WO2004033447A1 Imidazole derivatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 04/22/2004 | WO2004033423A2 Anticancer compounds |
| 04/22/2004 | WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 04/22/2004 | WO2004032931A1 Method for treatment of cancer |
| 04/22/2004 | WO2004005407A3 Tetra-azapentamethine and use thereof for dyeing keratinous fibers |
| 04/22/2004 | WO2003072541A3 Chemical compounds |
| 04/22/2004 | WO2002094794A8 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2000061134A9 Antimicrobial agents |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077868 Process |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077696 Heterocyclic inhibitors of kinases |
| 04/22/2004 | US20040077618 Epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, neuroprotection, movement disorders; 2-methylcyclohexanecarboxamide, or 1,1':1',1''-ter(cyclopropane)-2'-carboxamide, or (cis)(2S)-2-((((3R,5S)-3,5-dimethylcyclohexyl) carbonyl)amino)propanoic acid for example |
| 04/22/2004 | US20040074016 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing |
| 04/22/2004 | DE10247578A1 Functionalized ionic liquids obtained by a new, more efficient and low-cost method, used as solvents in catalytic reactions or as extractants, entrainers, wash liquids, heat transfer media, surfactants, modifiers and plasticisers |
| 04/22/2004 | CA2501901A1 Anticancer compounds |
| 04/22/2004 | CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1409461A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
| 04/21/2004 | EP1408919A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye |
| 04/21/2004 | EP1261666B1 A method of colouring hair using cationic dyes |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1154987B1 Phenylalaninol derivatives |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491218A Method for preparing compounds derived from thiazolidinedione, oxazolidinedione |
| 04/21/2004 | CN1491216A Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/21/2004 | CN1146560C Substituted benzoylpyrazoles as herbicides |
| 04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 04/21/2004 | CN1146550C Halogenated pyrimidines and its application as method for reducing parasite |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/21/2004 | CN1146467C Cyclic carbamide surfactant |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
| 04/15/2004 | WO2004031160A2 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 04/15/2004 | WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/15/2004 | WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 04/15/2004 | WO2004031129A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 04/15/2004 | WO2004030674A1 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist |
| 04/15/2004 | WO2004030611A2 Non-nucleoside reverse transcriptase inhibitors |
| 04/15/2004 | WO2004009558A3 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 04/15/2004 | WO2003103567A3 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors |
| 04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
| 04/15/2004 | WO2003053359A3 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | US20040073046 Crosslinking polyurethanes |
| 04/15/2004 | US20040073035 Removal by salt formation |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072843 Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |